Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Bayer Aktienges ADR
(OP:
BAYRY
)
7.050
+0.010 (+0.14%)
Streaming Delayed Price
Updated: 3:59 PM EDT, Jun 18, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
815,829
Open
7.040
Bid (Size)
N/A (0)
Ask (Size)
N/A (0)
Prev. Close
7.040
Today's Range
7.040 - 7.090
52wk Range
6.960 - 14.70
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Judge Slashes Bayer's Massive $2B Roundup Verdict To $400M
June 05, 2024
Pennsylvania judge cuts Bayer's $2.25 billion Roundup verdict to $400 million. Both Bayer and plaintiff plan appeals in the ongoing cancer litigation.
Via
Benzinga
Exposures
Glyphosate
Week In Review: MediLink And BioNTech Form $1.8 Billion ADC Partnership
June 01, 2024
Suzhou MediLink partnered with Germany’s BioNTech to use MediLink’s TMALIN antibody-drug conjugate platform. MediLink will receive an upfront payment of $25 million and up to $1.8 billion in...
Via
Talk Markets
Performance
YTD
-24.84%
-24.84%
1 Month
-10.42%
-10.42%
3 Month
+0.84%
+0.84%
6 Month
-19.70%
-19.70%
1 Year
-49.39%
-49.39%
More News
Read More
European Equities Close Higher As Traders Bank On Imminent ECB Rate Cut: What's Driving Markets Monday?
May 27, 2024
Via
Benzinga
After UnitedHealth Cyberattack, Drug Distributor Cencora Notifies Americans' Health Information Stolen In Data Breach In February
May 24, 2024
Via
Benzinga
Topics
Data Breach
Exposures
Information Security
Bayer Highlights Detailed Data From Twin Late-Stage Trials On Experimental Menopause Candidate, Seeks Regulatory Approval
May 17, 2024
Via
Benzinga
Pfizer, AstraZeneca, Sanofi And Mainz Biomed To Uplevel Europe's Pharma Game
May 16, 2024
Via
Benzinga
BAYRY Stock Earnings: Bayer Beats EPS, Misses Revenue for Q1 2024
May 14, 2024
Via
InvestorPlace
From Hype To Reality, AI Reshapes Pharmaceutical Industry Across Drug Discovery To Marketing - Stocks To Watch
May 10, 2024
Via
Benzinga
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Bayer's Monsanto Scores Legal Victory as $185M Verdict Overturned
May 02, 2024
Via
Benzinga
Exposures
Glyphosate
Alphabet, Nasdaq, Spotify, Teck Resources And A Major Financial Stock On CNBC's 'Final Trades'
April 10, 2024
Via
Benzinga
Google Partners With European Conglomerate Bayer For New AI-Powered Solutions For Radiologists
April 09, 2024
Via
Benzinga
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Wondering Where To Find An Over 7% Annual Return? Check Out These 10 Investment-Grade Corporate Bonds
April 05, 2024
Via
Benzinga
Topics
Bonds
Exposures
Debt Markets
Bayer-Backed Boundless Bio Falls After IPO
March 31, 2024
Via
Talk Markets
Dyadic Intl. Inc. (NASDAQ: DYAI) Potential Strategic Alliances with Future of Foods Boosts Stock as Key Conference Looms
March 19, 2024
Via
AB Newswire
Topics
Supply Chain
Exposures
Supply Chain
Bayer's Third Menopausal Relief Drug Trial Meets Primary Goal, German Conglomerate Seeks FDA Approval For Elinzanetant
March 19, 2024
Via
Benzinga
Exposures
Product Safety
German Conglomerate Bayer Goes Johnson & Johnson Way To Tackle Its Cancer Related Lawsuits
March 14, 2024
Via
Benzinga
Topics
Bankruptcy
Lawsuit
Exposures
Financial
Glyphosate
Legal
BAYRY Stock Earnings: Bayer Beats EPS, Misses Revenue for Q4 2023
March 05, 2024
Via
InvestorPlace
Bayer Holds Splitting Into Separate Units For Three Years, Focus Shifts On Tackling Challenges
March 05, 2024
Via
Benzinga
Biotechs on the Rise: 3 Stocks to Buy for a Shot of Profits
March 04, 2024
Via
InvestorPlace
What's Going On With BridgeBio Pharma Stock On Monday?
March 04, 2024
Via
Benzinga
Exposures
Product Safety
BridgeBio, A Top 3% Biotech, Just Snagged A $310 Million Deal; Will Shares Break Out?
March 04, 2024
Via
Investor's Business Daily
Cathie Wood Just Bought These 3 Biotech Stocks. Should You Buy, Too?
March 01, 2024
Via
InvestorPlace
3 Overextended Stocks That Need to Slash Their Dividends ASAP
February 27, 2024
Via
InvestorPlace
MAIA Biotechnology: Undervalued With Eye-Popping Cancer Data And Partnership Potential
February 22, 2024
Via
Talk Markets
Week In Review: I-Mab Morphs Into US-Only Company; Sells China Assets For $80 Million
February 11, 2024
Via
Talk Markets
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.